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Macrophages  interact  with  immunoglobulin  G  via  cell  surface  receptors  that 
recognize and bind the Fc portion of IgG. In the mouse, these Fc receptors (FcR) 1 are 
specific  for  IgG subclasses.  A  common  FcR  that  is  resistant  to  trypsin  recognizes 
aggregated or immune-complexed IgG1 and IgG~b at high affinity but has low affinity 
for the monomeric proteins  (1-3). There is a distinct FcR with similar properties for 
IgG3 (4). A  third FcR is trypsin sensitive and has high affinity for monomeric IgG2a 
(1,  2).  Cellular  functions can be regulated by both the intact  IgG molecule and by 
proteolytic fragments of IgG. Although not all the functions of Fc-mediated binding 
of intact  IgG  or  IgG  in  immune  complexes  to  the  cell  surface  FcR  are  clearly 
understood, the IgG-FcR interaction mediates endocytosis of immune complexes and 
antibody-dependent cell-mediated cytotoxicity (5). 
Soluble Fc fragments from degradation of IgG by papain have also been shown to 
potentiate the immune response  (6).  These fragments can increase endogenous pro- 
duction of prostaglandin E by monocytes and of IgM by peripheral blood cells  (7). Fc 
fragments and subfragments have also been shown to be lymphocyte activators  (8- 
11). 
Because binding to the FcR involves the structure of the whole IgG molecule (12), 
proteinases that degrade the IgG molecule are likely to interfere with the function of 
the FcR and act as potential immunoregulators. Cells found at the site of acute and 
chronic inflammation, such as  inflammatory macrophages, may be a  source of IgG- 
degrading proteinases. One of the proteinases secreted by inflammatory macrophages 
is elastase (13). This metalloproteinase is a neutral endopeptidase capable of degrading 
elastin  (14) as well as other proteins such as c~l-proteinase  inhibitor (15).  In the study 
reported here, we investigated the proteolytic activity of mouse macrophage elastase 
on specific subclasses of mouse monoclonal IgG. 
Materials and Methods 
Materials.  Dulbecco's  modified  Eagle's  medium  (complete  and  methionine  free) was ob- 
tained  from the Tissue Culture Facility,  University of California,  San Francisco, CA. Tissue- 
culture  flasks (T75; Costar,  Data Packaging, Cambridge,  MA) were purchased  from Microbi- 
ological  Associates (Walkersville,  MD).  Penicillin,  streptomycin,  fetal  bovine  serum,  and 
Dulbecco's phosphate-buffered  saline were purchased from Grand Island Biological Co. (Grand 
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Island, NY). IgG1 (MOPC 21), IgG2a (UPC 10, RPC 5), IgG2b (MOPC 195, MOPC 141), IgGa 
(FLOPC 21, Y 5606), IgM (TEPC 183), and IgA (MOPC 315) were obtained as purified mouse 
myeloma proteins from Bionetics Laboratory Products (Kensington, MD). Monoclonal mouse 
anti-sheep er~throcyte (SRBC) IgG3 was purified from culture medium of N-S.7 cells (16), and 
IgG2b anti-Ia  was purified from culture medium of 10-2.16 cells (Cell Distribution Center, Salk 
Institute for Biological  Studies, San Diego, CA). Monoclonal mouse IgG2b (Sp2/HL) and IgG~ 
(Sp3/HL) were purified from culture medium obtained from Accurate Chemical & Scientific 
Corp.  (Westbury, NY).  Human IgGa was  a  gift  of G. Crabtree of the National Institutes of 
Health, Bethesda, MD.  Human a~-proteinase inhibitor (al-antitrypsin) was  purchased from 
Worthington Biochemical Corp.  (Freehold, N  J).  Tris (Trizma base), sodium dodecyl sulfate 
(SDS),  1,10-phenanthroline, phenylmethanesulfonylfluoride  (PMSF), EDTA, and 2-mercap- 
toethanol were  purchased  from  Sigma Chemical  Co.  (St.  Louis,  MO).  All eleetrophoresis 
reagents (electrophoresis  grade) were purchased from Bio-Rad Laboratories (Richmond, CA). 
[35S]Methionine  (>1,200 Ci/mmol) was purchased from Amersham Corp. (Arlington Heights, 
IL). Protein A-Sepharose was purchased  from Pharmacia Fine Chemicals (Piscataway, N  J). 
IgSorb was purchased from the Enzyme Center (Boston,  MA). Acetyl-Ala-Ala-Ala-Ala-chlo- 
romethyl ketone [Ac(AIa)4CH2CI] was a gift ofJ. C. Powers,  Georgia Institute of Technology, 
Atlanta, GA. YM 10 and XM50 uhrafihration membranes were purchased from Amicon Corp. 
(Danvers, MA). 
Macrophage Elastase.  The active form of macrophage elastase was  purified from medium 
conditioned by thioglycollate-elicited mouse peritoneal maerophages as previously described 
(14). The preparations used were >5,000 U/rag protein. 
Polyacrylamide Gel  Electrophoresis.  SDS-polyacrylamide gels  were  prepared  and  run  by  a 
modification of the method of Laemmli (17). Samples were applied to a 3% (wt/vol) polyacryl- 
amide stacking gel on a linear 8-20% (wt/vol) polyacrylamide gel slab (0.75 X  10 ×  10 cm). 
Gels were run at room temperature at 20 mA/gel. After electrophoresis the protein bands were 
fixed in the gel by 20% (wt/vol) trichloroacetic acid at 4°C and stained with 0.05% Coomassie 
Brilliant Blue R250 dissolved  in 20%  (wt/vol) methanol. Radiolabeled IgG were located by 
autoradiography on prefogged Kodak X-Omat AR film (Eastman Kodak Co., Rochester, NY) 
at -80°C (18). 
Proteolytic Reaction Mixtures.  Macrophage elastase was incubated at 37°C with IgG (1:100, 
wt/wt) in 18 mM Tris-HCl, pH 8.0, containing 10 mM CaCI2 and 30 mM NaCI, for  1-20 h. 
Usually 0.1/lg of macrophage elastase (0.5 U, where 1 U degraded 1/.tg of insoluble elastin/h) 
was incubated with  10 #g of immunoglobulin.  Typical reactions were carried out in 15-btl vol 
with reactant concentrations of 6.67 ~ug/ml (33.33 U/ml) elastase and 0.67  mg/ml immuno- 
globulin. When Fc fragments were used as substrates they were incubated at a  1:100 ratio in 
0.15 M Tris-acetate buffer, pH 7.4. Reactions were stopped by the addition of EDTA to a final 
concentration of 30 mM. When proteinase inhibitors were included in the reaction mixtures, 
they were preincubated with macrophage elastase for 30 min at room temperature. PMSF was 
dissolved in isopropanol and used at  1 mM. 1,10-Phenanthroline was dissolved in ethanol and 
used at  1 mM. Inhibition was determined with reference to solvent controls. Ac(Ala)4CH2CI 
and ax-proteinase inhibitors were prepared in Tris-HC1, pH 8.0. 
Radiolabeling of IgG.  Radioiodination of IgG2a was done with Na12SI by the ehloramine T 
method (19). IgG3 was biosynthetically labeled by growing N-S.7 cells for 24 h in methionine- 
free Dulbecco's modified Eagle s medium containing [aSS]methionine  (25/~Ci/ml). The condi- 
tioned medium was  adjusted to pH  8.0  with solid Tris base and passed over a  protein A- 
Sepharose column (9 × 0.9 cm). Chromatography was carried out at 30 ml/h at 4°C. IgG3 was 
eluted with 0.1 M citrate buffer, pH 3.0 (20). Fractions were collected into sufficient 1 M Tris 
base to give a final pH of 7.0-7.5.  Fractions containing IgG~  were pooled and concentrated on 
an XM50 membrane with the buffer changed to 0.05 M Tris-HC1, pH 8.0. 
Adsorption of IgG Cleavage Products to Protein A.  Intact IgG or IgG-macrophage elastase reaction 
mixtures were incubated at 0°C in 0.01 M Tris-HCl, 0.015 M CaCI2, pH 8.0, for 40 min with 
sufficient excess IgSorb (formalin-fixed Staphylococcus aureus, Cowan strain I, containing protein 
A) to bind twice the amount of IgG present. The protein-IgSorb complexes were collected by 
centrifugation for 5 min in a  Microfuge B (Beckman Instruments, Inc.,  Palo Alto, CA). The 
supernatants contained the material lacking an Fc region, and the pellet contained intact IgG 1186  LIMITED  PROTEOLYSIS  OF IgG  BY  MACROPttAGE  ELASTASE 
and proteolytic fragments with Fc regions. The pellet was washed with 0,01  M  Tris-HCl,  pH 
8.0. Both supernatant and pellet were then analyzed by SDS-polyacrylamide gel electrophoresis 
under nonreducing conditions. 
Fc  Receptor  Binding  Studies.  P388D1  macrophages,  maintained  in  culture  by  established 
methods  (21),  were  used  to  evaluate  the ability of IgG2a  cleaved  by  macrophage  elastase  to 
compete with intact [125IIigG2,  for the specific IgG2~ FcR. Detailed methods for the competition 
experiments are described elsewhere (1, 2). 
Fc Fragments.  IgGz~ (UPC  10)  (2 rag) was incubated with papain (1:500 enzyme/substrate, 
wt/wt)  for  12 h  at  37°C  in 0.02  M  Tris-buffered saline, 0.01  M  EDTA,  pH 8.1.  The reaction 
mixture  was  then  passed  over a  protein  A-Sepharose  column  at  4°C.  Proteolytic  fragments 
without  Fc regions were contained in the pH  8.0 eluate,  Intact  IgG2a and  Fc fragments were 
eluted  together  at  pH  3.0  and  then  concentrated  by  uhrafihration on  a  YM10  membrane. 
IgG2,  was  fully  separated  from  the  Fc  fragments  after  size-exclusion  chromatography  on  a 
Spherogel-TSK 2000-SW column  (Ahex, Berkeley, CA)  in 0.15 M  Tris-acetate, pH  7.4, at  1.0 
ml/min on a  1084B liquid chromatograph (Hewlett-Packard Co., Palo Alto, CA). Intact IgG2, 
eluted at  13.5  rain and the 58,000-mol wt Fc fragment eluted at 21.6 min. No other peaks were 
detected at 280 nm. Molecular weights were determined on SDS-polyacrylamide electrophoresis 
gels under nonreducing conditions, 
Results 
Proteolysis of IgG Subclasses by Macrophage Elastase.  Monoclonal  mouse IgG1,  IgG2a, 
IgG2b, and  IgG3 were used as substrates  for purified mouse macrophage  elastase.  Of 
these IgG subclasses, only IgG1 was resistant to degradation  (Fig.  1). When analyzed 
by SDS-polyacrylamide  gel electrophoresis under nonreducing conditions (Fig.  1), the 
proteolysis of IgG2a and IgG3 resulted in nearly identical  major peptides with sizes of 
105,000  and 24,000 tool wt  (IgGza) and  113,000 and 23,000 mol wt  (IgGa),  as well as 
FIG.  1.  Limited proteolysis of IgG by macrophage elastase.  SDS-polyacrylamide gradient gels with 
samples applied unreduced. Lanes a and b show IgG2a (UPC 10); c and d IgGzh (MOPC  141); e and 
fIgG3 (FLOPC 21); g and h human IgG1. Lanes a, c, e, and g show  15 h  incubation of IgG with 
macrophage e[astase inhibited with  l0 mM EDTA.  Lanes b, d,f, and h show IgG incubated with 
active macrophage elastalse for  15 h.  Molecular weight  markers  (×  10  -3)  are shown at  left.  The 
major cleavage fragments produced under nonreducing conditions from IgG2a (lane b) were 144,000, 
105,000, and 24,000 tool wt; from IgG2b (lane d),  151,000,  116,000, 89,000,  50,000, and 22,000 tool 
wt;  from IgG~ (lane f),  113,000,  96,000,  23,000,  and  14,000 mol wt;  from human IgG1 (lane h), 
137,000,  109,000, and 28,000 mol wt. BANDA ET AL.  1187 
a minor cleavage peptide of 144,000 tool wt from IgG2,. The proteolysis of IgGzb was 
more complicated.  Not all forms of monoclonal IgG2b were degraded. There was no 
detectable  degradation  of IgG2b  secreted  by  Sp2/HL,  whereas  IgG2u  secreted  by 
10-2.16,  MOPC  195,  and  MOPC  141  were  degraded  nearly  to  completion.  The 
proteolysis of IgG2b resulted  in the production of approximately the same size major 
peptides  detected  from IgG2, and  IgG3, plus two additional  peptides  of 89,000 and 
50,000 mol wt. 
Because it binds to the mouse IgG2a FcR, we also used human IgGa as a  substrate 
for macrophage elastase  (Fig.  1). The resulting proteolytic peptides were identical to 
those produced by the proteolysis of IgG2, and IgGa. 
Macrophage elastase also degraded mouse IgM and IgA. However, the cleavage of 
these immunoglobulins was more limited than the cleavage of IgG. The subclasses of 
immunoglobulins degraded by macrophage elastase are summarized in Table I. 
Time  Course of Proteolysis of IgG.  To  determine  the  rate  at  which  macrophage 
elastase degrades immunoglobulins, IgG2,, and a susceptible IgG2b were incubated for 
times up to 20 h  (Fig. 2). SDS-polyacrylamide gel electrophoresis under nonreducing 
conditions showed that at a  1:100 ratio  (enzyme/substrate,  wt/wt)  the proteolysis of 
IgG2, was detectable after  1 h  of incubation but that the  144,000-mol wt peptide was 
most prominent  and remained prominent  throughout  15 h  of incubation.  Proteolysis 
of IgG2, did not approach completion until the reaction mixtures had been incubated 
for at  least  20 h. This suggests that the proteolysis of IgG2~ proceeded in two stages, 
first  the production  of the  144,000-mol wt peptide,  then  further  degradation  to the 
105,000-  and  24,000-mol  wt  peptides.  The same  results  were  found with  IgG3 (not 
shown).  In contrast,  the more complex degradation  of IgG2b proceeded without  the 
apparent  accumulation of a  particular cleavage peptide. 
TABLE  I 
Proteolysis of Immunoglobulins by Macrophage Elastase 
Light  Degraded by 
macrophage  Species  Ig type  Cell type  chain type  elastase* 
Mouse  IgG1  Sp3/HL  ND~  No 
MOPC 21  t¢  No 
IgG2a  UPC 10  ~  Yes 
RPC 5  ~  Yes 
IgG~b  MOPC 141  K  Yes 
MOPC 195  ~  Yes 
Sp2/HL  ND  No 
10-2.16  ND  Yes 
Ig'G3  FLOPC 21  ~¢  Yes 
Y 5606  ~.  Yes 
N-S. 7  ~¢  Yes 
IgA  MOPC 315  ~  Slightly 
IgM  TEPC 183  r  Slightly 
Human  Ig,  Gl  Yes 
* Degradation was assessed at  a  1:100 ratio  (enzyme/substrate, wt/wt)  and 
was considered positive if discrete cleavage peptides were detectable after 20 
h at  37°C by SDS-polyacrylamide gel electrophoresis. At least two experi- 
ments were performed for each Ig type. 
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Fro.  2.  Time course of the degradation of IgG by macrophage elastase. Reaction mixtures of 
macrophage elastase with IgG2a (UPC 10) or IgG2b (MOPC 141) were incubated for the times 
indicated, then analyzed unreduced on  SDS-polyacrylamide gradienl  gels. Molecular weight 
markers (× 10  -a) are shown at [ef~. 
Effect  of Proteinase Inhibitors  on  the  Degradation of IgG  by  Macrophage Elastase.  To 
demonstrate  that  the  cleavage of IgG2, is  the  result  of proteolysis  by  macrophage 
elastase, we  investigated  the effect of proteinase inhibitors  that  distinguish  metallo- 
proteinases  from serine proteinases.  Some of these inhibitors  specifically distinguish 
macrophage elastase activity from granulocyte elastase activity. Fig.  3 demonstrates 
that, of the inhibitors used, only the metal chelators,  1,10-phenanthroline and EDTA, 
at  1 mM, inhibited macrophage elastase-mediated proteolysis of IgG. Neither PMSF 
(1 mM), a general serine proteinase inhibitor, nor Ac(AIa)4CH2C1 (0.1 mM), a specific 
inhibitor of both granulocyte and pancreatic elastase (22), inhibited degradation more 
than solvent controls (not shown). Organic solvents used to solubilize these inhibitors 
are slightly inhibitory to macrophage elastase (14).  Because the metal chelator  1,10- 
phenanthroline  completely inhibited  degradation,  the  limited  proteolysis of immu- 
noglobulins  seen  in  this  study  could  not  be  attributed  to  contamination  by serine 
proteinases.  The  serum  inhibitor  of serine  proteinases,  c~t-proteinase  inhibitor,  also 
did  not  prevent degradation of IgG2a by macrophage elastase, but  rather acted  as a 
competitive substrate  for macrophage elastase  (15),  resulting  in  less  than  complete 
degradation of IgG2a. 
Characterization of Proteolytic Fragments.  To determine which chain of the immuno- 
globulin is recognized and cleaved by macrophage elastase, we analyzed the proteo- 
lyric reaction mixtures under reducing conditions on SDS-polyacrylamide electropho- 
resis gels.  Fig. 4 shows that macrophage elastase-mediated proteolysis of IgG2,, IgG2b, 
and IgG3 was restricted to the heavy chain and that IgG1 was resistant to degradation. 
Under these conditions the major proteolytic fragments of IgG2~ migrated as peptides 
of 33,000 and 31,000 mol wt, with minor small fragments. These gels also showed the 
accumulation of a 26,000-mol wt peptide from IgG2~ that was approximately the same 
size as  the  light  chain.  The  analysis of these  reaction  mixtures under  nonreducing 1189 
Fie.  3.  Effect ofproteinase inhibitors on the proteolysis oflgG2a (UPC 10) by macrophage elastase. 
SDS-polyacrylamide  gradient  gel.  Lane  a,  IgG2a  incubated  with  EDTA-inhibited  macrophage 
elastase at 37°C for  i5 h; b, IgG2~ incubated with active macrophage elastase at 37°C for 20 h. In 
lanes c f, IgG2, was incubated for 20 h at 37°C with active macrophage elastase plus (c)  1 mM 1,10- 
phenanthroline; d,  0. I  mM Ac(AIa)4CHzCI;  e,  1 mM PMSF; f,  1 mg/ml al-proteinase inhibitor. 
Lanes g-3  show Ig(32, incubated with  the same concentration  of inhibitors as in c-f but  without 
macrophage elastase.  Cleavage seen  in  lanes d  and  e was indistinguishable from  that  seen with 
elastase in the presence of solvent alone (not shown). Molecular weight markers (×  10  -'~) are shown 
at left. 
Fro.  4.  Limited proteolysis of the heavy chain of IgG by macrophage elastase. Reaction mixtures 
of macrophage  elastase with  IgGl  (MOPC  21),  IgG2.  (UPC  10),  IgG2b  (MOPC  141),  or  IgG3 
(FLOPC  21)  were analyzed after reduction  (0.5%  2-mercaploethanol at  100°C for 5 rain) on SDS- 
polyacrylamide gradient gels. Lanes marked a contain IgG incubated for 24 h without macrophage 
elastase.  Lanes  marked  b  contain  IgG  incubated  for  20  h  with  macrophage elastase.  Molecular 
weight  markers  (X  i0 -a)  are  shown  at  left.  The  cleavage  fragments  produced  under  reducing 
conditions from IgG2a were  33,000,  31,000,  26,000  (co-migrating with and slightly faster than the 
light chain), 23,000, and  16,000 tool  wt;  from IgG2b,  35,000 and 33,000 tool wl; from IgG3, 31,000 
and 14,000 mol wt. The 31,000-mol wt peptide produced from IgGa frequently resolved as a doublet. 1190  LIMITED PROTEOLYSIS  OF 18(3 BY MACROPHAGE  ELASTASE 
conditions (Fig.  1) showed the production of a 24,000-mol wt fragment. This fragment 
migrated with or near the light chain in the gel shown in Fig. 4. The degradation  of 
IgGa produced  peptides  of 31,000  and  14,000  mol  wt.  The  31,000-mol  wt  peptide 
frequently  resolved  as  a  doublet.  The  degradation  of IgGzb produced  peptides  of 
35,000 and 33,000 mol wt. 
Analysis by gel electrophoresis  (Fig. 4)  did not indicate any loss of the light chain, 
and susceptibility of IgG to cleavage by macrophage elastase could not be correlated 
to light  chain  type  (Table  I).  IgG1  (MOPC  21)  was kappa  light  chain  but  was not 
cleaved,  whereas  several  kappa light  chain  IgGza and  IgG2b substrates  were cleaved. 
All  three  forms of IgG3 that  were  tested  were  cleaved;  FLOPC  21  and  N-S.7  were 
kappa light chain, and Y5606 was lambda light chain. 
Because the heavy chain of IgG is degraded by macrophage elastase, we performed 
experiments  to  determine  which  proteolytic  fragment  contained  the  Fc  region.  To 
characterize  the  fragments  resulting  from  macrophage  elastase  proteolysis  of IgGza, 
IgG2b,  and  IgGa,  reaction  mixtures  were  absorbed  with  IgSorb,  which  binds  Fc 
fragments because of the interaction of the CH3 domain with protein A. The 24,000- 
mol  wt  fragment  was  adsorbed  to  protein  A  (Fig.  5),  which  indicates  that  this 
fragment contained  the Fc' portion of IgG2a. Because only the heavy chain of IgG2~ 
is degraded by macrophage elastase, coincident with the appearance of a band slightly 
smaller  than  the  light  chain  (Fig.  4),  this  24,000-mol wt  fragment  is  most  likely the 
Cn2  and  CH3  domain  of IgGza, which  is  consistent  with  an  Fc'-size fragment.  The 
33,000- and 31,000-tool wt fragments, which were also visible on reduced gels (Fig. 4), 
are two possible cleavage sites in the heavy chain. The  105,000-tool wt fragment that 
was  not  bound  by  protein  A  (Fig.  5)  lacks  an  Fc  region  and  is  consistent  with  an 
F(ab')2-size fragment. The  144,000-mol wt intermediate  degradation  product  (Fig. 2) 
Fro.  5.  Protein A absorption of IgG2a (UPC  10), IgG2b (10-2.16), and  IgG3 (FLOPC 21)  after 
degradation by macrophage elastase. Lanes contain (a) intact control IgG; (b) 20 h reaction mixture 
with macrophage elastase; (c) intact IgG adsorbed to protein A; (d) reaction mixtures of IgG and 
macrophage elastase adsorbed to protein A (pellet); (e) material from intact IgG not adsorbed to 
protein A (supernatants);  and  (f)  material from reaction mixtures not  adsorbed to protein A. 
Molecular weight markers (× 10 3) are shown at left. BANDA ET AL.  1191 
was also bound  by protein  A. Thi~ is consistent with an elastase cleavage near the 
hinge region in the CH2 domain, resulting in the release of a single Fc' fragment and 
leaving the molecule with one intact heavy chain that could still bind to protein A. 
The  proteolytic  fragments  of IgG3 were  similar  to  those  of IgG2, with  respect  to 
protein A binding (Fig. 5). 
All  of the proteolytic fragments of IgG2b were absorbed by protein  A  except  the 
50,000-mol wt peptide. It is likely that the IgGzb cleavage points are above the hinge 
region at the end of the CH 1 domain and below the hinge region at the beginning of 
the CH2 domain. 
Effect of Proteolysis by macrophage Elastase on the Binding of IgG2~ to FcR.  We performed 
an experiment to determine whether the fragments resulting from the limited prote- 
olysis of IgG by macrophage elastase can compete with intact IgG for binding to the 
FcR.  IgG2, was used as a  substrate  for macrophage elastase because the IgGza FcR 
binds monomeric IgG2a.  Aliquots of the reaction mixtures shown  in Fig.  5 or intact 
IgGza were  combined  with  a  constant  amount  of [125I]IgG2~ and  incubated  with 
P388D 1 macrophages (Table II). Intact IgG2~ inhibited binding of [125I]IgG2a  by 71%. 
After  20  h  of incubation  with  macrophage elastase,  the  degraded  IgG2a would  no 
longer efficiently bind to the FcR, as indicated by a reduction to only 27% inhibition 
of binding of [125I]IgG2~. Reaction mixtures that  included  the metal chelator,  1,10- 
phenanthroline (1 mM) inhibited the macrophage elastase proteolytic activity, allow- 
ing sufficient intact IgG2a remaining in the reaction mixture to inhibit the binding of 
[125I]IgG2~ by 62%. 
Proteolysis of Immune  Complexes by Macrophage Elastase.  The preceding experiments 
described the limited proteolysis of monomeric IgG by macrophage elastase. However, 
the  conformation  of  the  IgG  molecule  is  altered  in  an  immune  complex;  new 
proteolytic sites may be exposed while previously exposed ones are protected. Because 
of the conformational changes in an immunoglobulin involved in an immune complex, 
a series of experiments were performed to determine the ability of macrophage elastase 
to cleave IgG3 bound to SRBC. The IgGs anti-SRBC that was biosynthetically labeled 
with  [SSS]methionine  was  used  to  opsonize  SRBC.  The  reaction  mixtures  of these 
immune complexes with macrophage elastase were analyzed by autoradiography of 
SDS-polyacrylamide gels that were run under reducing conditions.  A  densitometric 
scan of the autoradiograph showed that macrophage elastase degraded  IgGs bound 
TABLE  II 
Competition of Macrophage Elastase (ME)-degraded IgG2a with [t~I]IgG2a 
for Binding to P388D1 IgG2a FcR 
Competing reaction mixture 
Inhibition 
Incuba-  of [lzsI]- 
tion time  IgGza 
binding 
None 
Intact IgG~a 
ME-IgG~ 
Me-IgG~ 
ME-IgG~ + PMSF (1 mM) 
ME-IgG2a +  1,10-phenanthroline (1 mM) 
h  % 
0 
20  71 
15  40 
20  27 
20  30 
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Fxc.  6.  Densitometric scan of an autoradiograph of SDS-polyacrylamide gradient gels of reduced 
[3'SS]methionine-labeled mouse IgG3 anti-SRBC  (N-S.7).  Panel  a  shows intact  soluble  IgG~ anti- 
SRBC, b shows macrophage elastase-degraded soluble IgGa anti-SRBC, c shows intact  IgG3 anti- 
SRBC that  was bound to SRBC, and d shows IgG;j anti-SRBC degraded by macrophage elastase 
while bound to SRBC. The arrows in  panels b and d indicate the cleavage fragments common to 
both soluble and imnmne-coroplexed IgG3-macrophage elas~ase reaction mixtures. The bracket  in 
panel d indicates cleavage fragments characteristic of immune-complexed IgGa-macrophage elastase 
reaction  mixtures. The  relative  positions of the heavy  (H)  and  light  (L)  chains are  indicated  in 
panels a and b. 
Fro.  7.  Degradation  of lgG2a  (UPC  10)  Fc  fragments  by  macrophage  elastase.  Samples  were 
applied  unreduced  to  SDS-polyacrylamide  gradient  gels.  (a)  Unincubated  Fc  fragment;  (b)  Fc 
fragment incubated for 5 h  at 37°C without macrophage elastase;  (c)  Fc fragment incubated for  1 
b  at 37°C with macrophage elastase. Molecular weights of the degraded Fc fragments (×  10  -3) are 
shown at right. BANDA ET AL.  1193 
in an  immune complex (Fig.  6).  Although  the cleavage by macrophage elastase of 
IgG3  in  immune  complexes  differed  from  the  cleavage of monomeric  IgG3,  there 
remain some important similarities.  Whereas the cleavage of monomeric IgG3 gave 
two cleavage products, 32,000 and 31,000 mol wt, of the heavy chain, Fig. 6 indicates 
that the proteolysis of immune-complexed IgG3 was still limited to the heavy chain 
but  that  the 32,000-mol wt  heavy chain  fragment was  not  a  degradation product. 
With  immune-complexed  IgG3  there  was  also  an  increase  in  the  production  of 
fragments smaller than the light chain. One result of the removal of the Fc portion of 
IgG~ by macrophage elastase would be that the IgG3-SRBC immune complex could 
not be bound by the FcR and therefore would not be phagocytized. 
Proteolysis of the Fc Fragments by  Macrophage Elastase.  Fc  fragments  generated  in 
tissues by proteinases such as granulocyte elastase are conformationally different from 
the Fc region of the intact immunoglobulin. We investigated the possibility that an 
Fc  fragment  produced  by  another  proteinase  would  present  additional  sites  for 
proteolysis by macrophage elastase. A 58,000-mol wt papain-generated Fc fragment 
of IgG2a, which is similar to an Fc fragment produced by granulocyte elastase, was 
incubated for up to 5 h  with macrophage elastase. Fig.  7 shows that degradation of 
this  fragment was  detected after only  1 h  of incubation at  pH  7.4.  The fragments 
produced had apparent  molecular weights from 43,000 to  15,000  mol wt on nonre- 
ducing SDS-polyacrylamide gels. 
Discussion 
We have shown  that  mouse macrophage elastase selectively cleaves mouse IgG2a, 
IgG3, and human IgG1 into F(ab')2-1ike and Fc'-like subfragments. These peptides are 
similar to the proteolytic fragments produced by pepsin rather than those produced 
by papain.  Not all of the monoclonal IgG2b preparations that we investigated were 
degraded by macrophage elastase,  and  the  IgG2b forms that  were susceptible were 
degraded into more peptide fragments than were IgG2a and IgG3. 
The susceptibility of immunoglobulins to cleavage was independent of the type of 
light chain because immunoglobulins were degraded whether they contained kappa 
or lambda light chain. There was no indication of the cleavage of light c.hain in any 
of the experiments performed. The susceptibility of IgG to proteolysis by macrophage 
elastase did vary with the conformational state of the IgG molecule. The proteolysis 
of IgGz in immune complexes differed from the proteolysis of monomeric IgG3. The 
apparent  two-stage  degradation  of monomeric  IgGza  and  IgG3  suggests  that  the 
conformation of the first proteolysis product, 144,000 mol wt, where one heavy chain 
had been cleaved, was less favorable for degradation than was the intact molecule. 
The  time course of proteolysis  (Fig.  2)  indicates  that  immunoglobulins  are  less 
favored substrates for macrophage elastase than is al-proteinase inhibitor. When these 
two  proteins  were  used  as  substrates  under  identical  conditions  (1:100  enzyme/ 
substrate, wt/wt), all of the native al-proteinase inhibitor was degraded in 4 h  (15), 
whereas the total degradation of native IgG  (this study)  required at  least  20 h.  al- 
Proteinase inhibitor was degraded at a rate of 9.48 tool h -1  (tool elastase) -1, whereas 
IgG was degraded at 0.67 mol h -1  (mol elastase) -1, a  14-fold lower rate. Also, when 
al-proteinase  inhibitor  was  used  in  the  inhibitor  experiments  with  macrophage 
elastase (Fig. 3), it was cleaved preferentially. 
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functions  (23).  Of the  susceptible  IgG  subclasses,  IgG2,  and  IgGa  have  different 
receptors, whereas IgG1 and IgG2b share an FcR distinct from the IgG2a FcR and the 
IgGa  FcR  (3).  Whether  the  fact  that  IgGI  and  some  forms of IgG2u  were  poorly 
degraded by macrophage elastase is coincidental or indicative of a regulatory scheme 
involving proteolysis of IgG and the interaction with the FcR is not known. Guinea 
pig  peritoneal  macrophages  rapidly  degrade  soluble  immune  complexes once  the 
complexes are bound  to the  FcR  (24).  The amount  of elastase used  in  the present 
study (0.5  U) was equivalent to the active elastase present near the surface of as few 
as 5  X  10  4 inflammatory macrophages (25). 
The data presented here show that  degradation by macrophage elastase prevents 
binding  of monomeric IgG to  the  FcR  and  suggest  that  phagocytosis of immune- 
complexed  IgG  is  also  impaired  because  of degradation  by  macrophage  elastase. 
Because  the  integrity  of the  Fc  region  is  required  for  antigen-antibody  complex- 
mediated suppression (26), macrophage elastase may also interfere with suppression. 
The nature of the cleavage of IgG by mouse macrophage elastase differs from the 
cleavage of IgG mediated  by granulocyte elastase.  Human  granulocyte elastase,  a 
serine proteinase, readily produces papain-like  cleavages in  human  IgG1  and  IgGa 
and to a lesser extent IgG2 and IgG4 (27, 28). The result is the production of Fab and 
Fc  fragments  rather  than  the  F(ab')2-1ike  and  Fc'-like subfragments  produced  by 
mouse macrophage elastase, a metalloproteinase. 
More intriguing is the possible role that degradation of IgG and Fc fragments by 
macrophage etastase might have in lymphocyte activation and spleen cell mitogenesis. 
Fc fragments generated by papain, like those produced by granulocyte elastase, can 
induce  mouse  B  cells  to  proliferate  (8).  These  fragments  also  cause  B  cells  to 
differentiate into polyclonal antibody-secreting cells (8, 9). Macrophages are required 
for B cell activation (29) because they secrete proteinase into the culture supernatant 
that converts the papain-produced Fc fragment into a smaller peptide with mitogenic 
activity. The active fragment resulting from the macrophage-mediated degradation 
of Fc fragments elutes from a gel filtration column as a broad peak with an average 
of 14,000  mol wt (30) and more recently has been shown to be derived from the CH3 
domain of human IgG1 (31).  Macrophage elastase releases a fragment containing the 
CH3  domain  from  intact  mouse  IgG  as  well  as  from  human  IgG1.  Although  the 
24,000-mol wt Fc fragment was the major product of elastase degradation of intact 
IgG by macrophage elastase in this study, minor fragments as small as 14,000  mol wt 
were also produced (Figs. 4 and 5). It is therefore conceivable that in vivo macrophage 
elastase may participate in the production of mitogenic Fc subfragments from intact 
IgG. Thus,  macrophage elastase  may be a  key proteolytic regulator of lymphocyte 
mitogen production. 
The data reported here demonstrate that  macrophage elastase degrades selected 
IgG subclasses in a manner qualitatively different from that of proteinases from other 
inflammatory cells.  Because  macrophage  elastase  is  a  metalloproteinase,  it  is  not 
subject  to  inhibition  by cq-proteinase  inhibitor,  an  inhibitor of serine  proteinases. 
Thus,  degradation  of immunoglobulins  by  macrophage  elastase  may  continue  in 
situations  in  which  granulocyte  elastase,  plasmin,  or  other  serine  proteinases  are 
inhibited, resulting in a change in the type of IgG turnover. 
In  this report we have established  the potential  for macrophage elastase to be a 
regulator of some aspects of immunoglobulin-associated cellular events. The biologic BANDA ET AL.  1195 
role of the proteolytic fragments of IgG by this  macrophage  proteinase  will  require 
functional studies. 
Summary 
Mouse  macrophage  elastase,  a  metalloproteinase  secreted  by inflammatory  mac- 
rophages, catalyzed  the  limited  proteolysis of selected subclasses of mouse immuno- 
globulins,  including monomeric IgGza, IgG3, and  some forms of IgGzb. Mouse IgG1 
was resistant  to elastase  degradation;  however,  human  IgG1 was degraded.  IgG3 in 
immune  complexes  was  cleaved  in  a  manner  similar  to  that  of monomeric  IgG3. 
Degradation  by  macrophage  elastase  was  limited  to  the  heavy  chain,  resulting  in 
products  that  did  not  compete for binding to the  macrophage  Fc receptor.  Macro- 
phage elastase  usually  produced  a  pepsin-like  rather  than  a  papain-like  pattern  of 
proteolysis, resulting in the release of F(ab')2 and Fc' subfragments.  This degradation 
of IgG differed from the papain-like cleavage of IgG by granulocyte elastase.  Macro- 
phage  elastase  degraded  papain-generated  Fc  fragments  of  IgG2a  into  multiple 
fragments. Therefore, macrophage elastase at concentrations found in culture medium 
has  the  potential  to regulate  some aspects of cellular  events  associated  with  immu- 
noglobulins. 
Received  for publication 7 December 1982. 
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